BareedM. A., ScharfeT., BechtE., SchmidtJ., JacobiG. H., ThuroffJ. W.: In vitro chemosensitivity testing of renal cell cancer. Urology, 31; 240–244 (1988).
2.
BertelsenC. A., SondakV. K., MannB. D., KornE. L., KernD. H.: Chemosensitivity testing of human solid tumors. Cancer, 53; 1240–1245 (1984).
3.
ChangS. Y., YuD. S., MaC. P., HanS. H., YehM. Y.: In vitro chemosensitivity assay of human urologic malignancies. Eur. Urol., 16; 51–56 (1989).
4.
HamburgerA. W., SalomonS. E.: Primary bioassay of human tumor stem cells. Science, 197; 461–463 (1977).
5.
LieberM. M.: In vitro culture and chemosensitivity testing of human transitional cell carcinoma. Urol. Clin. N. Amer., 11; 725–733 (1984).
6.
SalmonS. E., HamburgerA. W., SoehnlenB. J.: Quantitation of differential sensivities of human tumor stem cells to anticancer drugs. N. Engl. J. Med., 298; 1321–1327 (1978).
7.
TismanG., HerbertV., EdlisH.: Determination of therapeutic index of drugs by in vitro sensitivity test using human host and tumor cell suspensions. Cancer Chemother. Rep., 57; 11–19 (1973).
8.
WeisenthalL. M., ShoemakerR. H., MarsdenJ. A.: In vitro chemosensitivity based on the concept of total tumors cell kill. Rec. Result Cancer Res., 94; 161–173 (1984).
9.
WeisenthalL. M., LippamM. E.: Clonogenic and non-clonogenic in vitro chemosensitivity assays. Cancer Treat. Rep.69; 615–632 (1985).
